The FASEB Journal · 2017 · 25 citations · 26 references
Life SciencesBiochemistryMolecular BiologyCell SignalingSignal TransductionTranscriptional RegulationDiabetes MellitusDiabetic NephropathyGlomerular PathophysiologyInflammatory SignalingRenal DiseaseRenal InflammationDiabetes Mellitus PathophysiologyDiabetes-related ComplicationsNf-kappa B-mediated Anti-apoptotic SignalingNf-κb SignalingNuclear Factor Kappa B ModulationNuclear Factor Kappa B SignalingNuclear Translocation Of Transcription FactorsPromoter-promoter Interactions
C-peptide (CP) has demonstrated unique beneficial effects in diabetic nephropathy (DN), but whether and how CP regulates NF-κB and its coactivator, p300, to suppress inducible iNOS and antagonize DN are unknown. iNOS expression, NF-κB nuclear translocation, colocalization and binding of NF-κB to p300, binding of NF-κB to the inos promoter, and the bound NF-κB, p300, and histone 3 lysine 9 acetylation (H3K9ac) at binding sites were measured in high glucose-stimulated mesangial cells. We evaluated pathologic changes, iNOS expression, NF-κB, and p300 contents in diabetic rats. We found that CP inhibited iNOS expression and notably prevented colocalization and binding of NF-κB and p300. CP prevented NF-κB from binding to the inos promoter, especially at the distal site, and reduced bound NF-κB, p300, and H3K9ac. N-terminal plus middle fragment could mostly mimic the antagonizing effects of CP against the pathologic changes of DN and equally suppresses renal iNOS expression as CP. In conclusion, CP prevented NF-κB from recruiting p300 and binding to the inos promoter, and decreased H3K9ac at the binding sites to suppress iNOS expression and antagonize DN, with the effect region identified as N-terminal plus middle fragment.-Li, Y., Li, X., He, K., Li, B., Liu, K., Qi, J., Wang, H., Wang, Y., Luo, W. C-peptide prevents NF-κB from recruiting p300 and binding to the inos promoter in diabetic nephropathy.
26
Vadim S. Zinchuk, Olga Zinchuk, Teruhiko Okada · ACTA HISTOCHEMICA ET CYTOCHEMICA · 2007 · 425 citations · Full text
Prevention of Vascular and Neural Dysfunction in Diabetic Rats by C-Peptide
Yasuo Ido, Alessandro Vindigni, K. Chang et al. · Science · 1997 · 344 citations
Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
Zhuo Chen, Saul Genuth, Andrew D. Paterson et al. · Diabetes · 2014 · 251 citations · Full text
Role of Transcription Factor Acetylation in Diabetic Kidney Disease
Ruijie Liu, Yifei Zhong, Xuezhu Li et al. · Diabetes · 2014 · 217 citations · Full text